Vor Bio secures $55.6M in private funding, boosting stock as it advances biopharm research.
Vor Bio, a biotechnology company, has announced the successful completion of a $55.6 million private placement, leading to a surge in its stock price. This financial move is expected to support the company's ongoing research and development in biopharmaceuticals.
3 months ago
4 Articles
You have 5 free stories remaining this month. Subscribe anytime for unlimited access.